X4 Pharmaceuticals, Inc. Common Stock XFOR
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-03T15:44:59.316Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T15:44:55.377237393Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-03T15:35:48.514933+00:00
X4 Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 2.80 | 353.3% | 37.9% | |||
| 30Δ | 3.33 | 380.6% | 35.1% | |||
| 35Δ | 3.86 | 407.9% | 32.4% | |||
| 40Δ | 4.40 | 435.1% | 29.7% | |||
| 45Δ | 4.93 | 462.4% | 27.0% | |||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | ||||||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | 4.73 | 800.0% | 103.0% | |||
| 80Δ | 3.61 | 800.0% | 76.3% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.80
- IV
- 353.3%
- B/E move
- 37.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.33
- IV
- 380.6%
- B/E move
- 35.1%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.86
- IV
- 407.9%
- B/E move
- 32.4%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.40
- IV
- 435.1%
- B/E move
- 29.7%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.93
- IV
- 462.4%
- B/E move
- 27.0%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 4.73
- IV
- 800.0%
- B/E move
- 103.0%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 3.61
- IV
- 800.0%
- B/E move
- 76.3%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 249.20% |
Biotechnology
XNCR
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients…
More →ZBIO
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. The company is…
More →ZLAB
Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is…
More →ZNTL
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment of various cancers.…
More →ZURA
Zura Bio Limited (Ticker: ZURA) is a biotechnology firm dedicated to developing breakthrough therapies for autoimmune disorders and rare diseases. The company features a diverse…
More →ZVRA
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The…
More →